Literature DB >> 17088136

The lower airway pathology of rhinitis.

Giorgio Ciprandi1, Ignazio Cirillo.   

Abstract

There is a close link between allergic rhinitis (AR) and lower airways disorders, and this concept has been clarified and confirmed in several studies. AR constitutes a main risk factor for new-onset asthma. Furthermore, numerous epidemiologic surveys indicate that AR is very frequently associated with asthma. Bronchial hyperreactivity, a component of asthma, has often been reported to be present in patients with AR. Bronchial hyperreactivity in AR might represent a prognostic factor for further progress to asthma. In this regard forced expiratory flow at 25% and 75% of pulmonary volume has been proposed as an early marker of bronchial involvement in patients with AR who perceive only nasal symptoms. A close structural and functional relationship between the upper and lower airways has been recently demonstrated. Finally, adequate treatment of AR might positively affect the course of asthma. Taking these facts into consideration, a new diagnostic approach should be considered in managing patients with AR: a possible bronchial involvement must be sought in each patient.

Entities:  

Mesh:

Year:  2006        PMID: 17088136     DOI: 10.1016/j.jaci.2006.05.010

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  18 in total

1.  Airway IFN-γ production during RSV bronchiolitis is associated with eosinophilic inflammation.

Authors:  Chang Keun Kim; Zak Callaway; Young Yull Koh; Soo-Hee Kim; Takao Fujisawa
Journal:  Lung       Date:  2011-12-13       Impact factor: 2.584

2.  Association of nasal inflammation and lower airway responsiveness in schoolchildren based on an epidemiological survey.

Authors:  Jun-Ho Myung; Hyun-Jeong Seo; Soo-Jeong Park; Bo-Young Kim; Il-Sang Shin; Jun-Hak Jang; Yun-Kyung Kim; An-Soo Jang
Journal:  Korean J Intern Med       Date:  2015-02-27       Impact factor: 2.884

Review 3.  Treatment of Allergic Rhinitis as a Strategy for Preventing Asthma.

Authors:  Jaymin B Morjaria; Massimo Caruso; Rosalia Emma; Cristina Russo; Riccardo Polosa
Journal:  Curr Allergy Asthma Rep       Date:  2018-03-24       Impact factor: 4.806

Review 4.  Rodent models of allergic rhinitis: relevance to human pathophysiology.

Authors:  James G Wagner; Jack R Harkema
Journal:  Curr Allergy Asthma Rep       Date:  2007-05       Impact factor: 4.806

Review 5.  Nasobronchial interaction.

Authors:  Cemal Cingi; Nuray Bayar Muluk; Bengu Cobanoglu; Tolgahan Çatli; Oğuzhan Dikici
Journal:  World J Clin Cases       Date:  2015-06-16       Impact factor: 1.337

6.  Asthmatics without rhinitis have more fixed airway obstruction than those with concurrent rhinitis.

Authors:  An-Soo Jang; Jong-Sook Park; June-Hyuk Lee; Sung-Woo Park; Do-Jin Kim; Soo-Taek Uh; Young-Hoon Kim; Choon-Sik Park
Journal:  Allergy Asthma Immunol Res       Date:  2010-03-24       Impact factor: 5.764

7.  The role of inhaled and/or nasal corticosteroids on the bronchodilator response.

Authors:  Ju Kyung Lee; Dong In Suh; Young Yull Koh
Journal:  Korean J Pediatr       Date:  2010-11-30

8.  Recent developments in United airways disease.

Authors:  Giorgio Ciprandi; Davide Caimmi; Michele Miraglia Del Giudice; Mario La Rosa; Carmelo Salpietro; Gian Luigi Marseglia
Journal:  Allergy Asthma Immunol Res       Date:  2012-02-08       Impact factor: 5.764

9.  Severity of allergic rhinitis and asthma development in children.

Authors:  Giuseppe Di Cara; Alessia Carelli; Arianna Latini; Elisa Panfili; Ilaria Bizzarri; Giorgio Ciprandi; Serena Buttafava; Franco Frati; Alberto Verrotti
Journal:  World Allergy Organ J       Date:  2015-04-23       Impact factor: 4.084

10.  Rhinitis patients with sputum eosinophilia show decreased lung function in the absence of airway hyperresponsiveness.

Authors:  Min-Suk Yang; Hyun-Seung Lee; Min-Hye Kim; Woo-Jung Song; Tae-Wan Kim; Jae-Woo Kwon; Sae-Hoon Kim; Heung-Woo Park; Yoon-Seok Chang; Sang-Heon Cho; Kyung-Up Min
Journal:  Allergy Asthma Immunol Res       Date:  2013-05-03       Impact factor: 5.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.